Our Approach

Improving Accuracy with Molecular Cytology

Veracyte develops molecular tests that are designed to clarify ambiguous results obtained from cytology samples such as fine needle aspirates, helping to increase the diagnostic utility of these minimally invasive biopsies. Veracyte aims to enable doctors to make more informed treatment decisions that improve patient care and provide cost savings to the healthcare system.

• Collecting samples in large, prospective, multicenter clinical studies, comprising academic and community sites.
• Employing large numbers of “real world” samples during discovery – incorporating into the test at the outset the breadth of clinical samples that it may encounter – and as part of validation.
• Conducting whole-genome, empirically driven studies to identify genes that best differentiate benignity and malignancy.
• Utilizing powerful machine-learning algorithms and sophisticated statistical approaches to make sense of the large amount of genomic data.
• Developing multidimensional algorithms to empower classifier to ultimately make the best diagnosis possible.
• Implementing comprehensive laboratory process analytical validation studies.
• Considering sample collection, storage and shipping realities into scientific and clinical studies.
• Seeking input from relevant and experienced scientific and clinical thought-leaders.